#1FUZKK atlas leaders 1–100
Takeda Pharmaceutical
Japan · East Asia
Diversified pharma
Open article →FUZKK MULTI-REGION TOP 300
Asia + Middle East + Canada + Australia + Africa: Top 300 pharma companies
The unified atlas covers East and Southeast Asia, South and Central Asia, the Middle East, Canada, Australia and New Zealand, and Africa. Positions 1–100 are FUZKK atlas leaders; positions 101–300 extend regional coverage across manufacturers, biotech, generics, API/CDMO and specialty pharma.
300companies
100FUZKK atlas leaders 1–100
200Extended selection 101–300
35countries
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
#2FUZKK atlas leaders 1–100
Astellas Pharma
Japan · East Asia
Diversified pharma
Open article →#3FUZKK atlas leaders 1–100
Daiichi Sankyo
Japan · East Asia
Diversified pharmaOncology / ADC / high-potency
Open article →#4FUZKK atlas leaders 1–100
Otsuka Pharmaceutical
Japan · East Asia
Diversified pharmaPeptides and complex injectables
Open article →#5FUZKK atlas leaders 1–100
Eisai
Japan · East Asia
Diversified pharma
Open article →#6FUZKK atlas leaders 1–100
Chugai Pharmaceutical
Japan · East Asia
Diversified pharmaOncology / ADC / high-potency
Open article →#7FUZKK atlas leaders 1–100
Shionogi
Japan · East Asia
Diversified pharma
Open article →#8FUZKK atlas leaders 1–100
Sumitomo Pharma
Japan · East Asia
Diversified pharma
Open article →#9FUZKK atlas leaders 1–100
Kyowa Kirin
Japan · East Asia
Diversified pharmaPeptides and complex injectables
Open article →#10FUZKK atlas leaders 1–100
Ono Pharmaceutical
Japan · East Asia
Diversified pharmaOncology / ADC / high-potency
Open article →#11FUZKK atlas leaders 1–100
Taisho Pharmaceutical
Japan · East Asia
Consumer health / OTC
Open article →#12FUZKK atlas leaders 1–100
Tsumura
Japan · East Asia
Traditional and herbal medicines
Open article →#13FUZKK atlas leaders 1–100
Santen Pharmaceutical
Japan · East Asia
Ophthalmics
Open article →#14FUZKK atlas leaders 1–100
Nippon Shinyaku
Japan · East Asia
Baseline manufacturing scope
Open article →#15FUZKK atlas leaders 1–100
Mitsubishi Tanabe Pharma
Japan · East Asia
Finished dosage forms and small molecules
Open article →#16FUZKK atlas leaders 1–100
Sawai Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#17FUZKK atlas leaders 1–100
KM Biologics
Japan · East Asia
BiologicsVaccines and biological products
Open article →#18FUZKK atlas leaders 1–100
JCR Pharmaceuticals
Japan · East Asia
Peptides and complex injectables
Open article →#19FUZKK atlas leaders 1–100
Hisamitsu Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#20FUZKK atlas leaders 1–100
Asahi Kasei Pharma
Japan · East Asia
Finished dosage forms and small molecules
Open article →#21FUZKK atlas leaders 1–100
Samsung Biologics
South Korea · East Asia
Diversified pharmaBiologics
Open article →#22FUZKK atlas leaders 1–100
Celltrion
South Korea · East Asia
Diversified pharmaBiologics
Open article →#23FUZKK atlas leaders 1–100
SK Biopharmaceuticals
South Korea · East Asia
Biologics
Open article →#24FUZKK atlas leaders 1–100
SK bioscience
South Korea · East Asia
BiologicsVaccines and biological products
Open article →#25FUZKK atlas leaders 1–100
Yuhan Corporation
South Korea · East Asia
Baseline manufacturing scope
Open article →#26FUZKK atlas leaders 1–100
Hanmi Pharmaceutical
South Korea · East Asia
Finished dosage forms and small molecules
Open article →#27FUZKK atlas leaders 1–100
GC Biopharma
South Korea · East Asia
BiologicsVaccines and biological products
Open article →#28FUZKK atlas leaders 1–100
Daewoong Pharmaceutical
South Korea · East Asia
Finished dosage forms and small molecules
Open article →#29FUZKK atlas leaders 1–100
LG Chem Life Sciences
South Korea · East Asia
Baseline manufacturing scope
Open article →#30FUZKK atlas leaders 1–100
Chong Kun Dang
South Korea · East Asia
Baseline manufacturing scope
Open article →#31FUZKK atlas leaders 1–100
Samsung Bioepis
South Korea · East Asia
Biologics
Open article →#32FUZKK atlas leaders 1–100
Lotte Biologics
South Korea · East Asia
API / CDMO / synthesisBiologics
Open article →#33FUZKK atlas leaders 1–100
ST Pharm
South Korea · East Asia
API / CDMO / synthesis
Open article →#34FUZKK atlas leaders 1–100
Alteogen
South Korea · East Asia
Biologics
Open article →#35FUZKK atlas leaders 1–100
Hugel
South Korea · East Asia
Baseline manufacturing scope
Open article →#36FUZKK atlas leaders 1–100
ScinoPharm Taiwan
Taiwan · East Asia
API / CDMO / synthesis
Open article →#37FUZKK atlas leaders 1–100
TTY Biopharm
Taiwan · East Asia
Baseline manufacturing scope
Open article →#38FUZKK atlas leaders 1–100
Lotus Pharmaceutical
Taiwan · East Asia
Finished dosage forms and small molecules
Open article →#39FUZKK atlas leaders 1–100
EirGenix
Taiwan · East Asia
Biologics
Open article →#40FUZKK atlas leaders 1–100
Medigen Vaccine Biologics
Taiwan · East Asia
BiologicsVaccines and biological products
Open article →#41FUZKK atlas leaders 1–100
Kalbe Farma
Indonesia · Southeast Asia
Diversified pharma
Open article →#42FUZKK atlas leaders 1–100
Bio Farma
Indonesia · Southeast Asia
BiologicsVaccines and biological productsVeterinary pharma
Open article →#43FUZKK atlas leaders 1–100
Dexa Medica
Indonesia · Southeast Asia
Diversified pharma
Open article →#44FUZKK atlas leaders 1–100
Kimia Farma
Indonesia · Southeast Asia
Diversified pharma
Open article →#45FUZKK atlas leaders 1–100
Duopharma Biotech
Malaysia · Southeast Asia
Biologics
Open article →#46FUZKK atlas leaders 1–100
Pharmaniaga
Malaysia · Southeast Asia
Finished dosage forms and small molecules
Open article →#47FUZKK atlas leaders 1–100
Government Pharmaceutical Organization
Thailand · Southeast Asia
Vaccines and biological products
Open article →#48FUZKK atlas leaders 1–100
Siam Bioscience
Thailand · Southeast Asia
Biologics
Open article →#49FUZKK atlas leaders 1–100
DHG Pharma
Vietnam · Southeast Asia
Finished dosage forms and small molecules
Open article →#50FUZKK atlas leaders 1–100
United Laboratories
Philippines · Southeast Asia
Finished dosage forms and small molecules
Open article →#51FUZKK atlas leaders 1–100
Getz Pharma
Pakistan · South and Central Asia
Finished dosage forms and small molecules
Open article →#52FUZKK atlas leaders 1–100
The Searle Company
Pakistan · South and Central Asia
Baseline manufacturing scope
Open article →#53FUZKK atlas leaders 1–100
Square Pharmaceuticals
Bangladesh · South and Central Asia
Finished dosage forms and small molecules
Open article →#54FUZKK atlas leaders 1–100
Beximco Pharmaceuticals
Bangladesh · South and Central Asia
Finished dosage forms and small molecules
Open article →#55FUZKK atlas leaders 1–100
Incepta Pharmaceuticals
Bangladesh · South and Central Asia
Finished dosage forms and small molecules
Open article →#56FUZKK atlas leaders 1–100
Renata
Bangladesh · South and Central Asia
Baseline manufacturing scope
Open article →#57FUZKK atlas leaders 1–100
Nobel Almaty Pharmaceutical Factory
Kazakhstan · South and Central Asia
Finished dosage forms and small molecules
Open article →#58FUZKK atlas leaders 1–100
SANTO Member of Polpharma Group
Kazakhstan · South and Central Asia
Finished dosage forms and small molecules
Open article →#59FUZKK atlas leaders 1–100
Jurabek Laboratories
Uzbekistan · South and Central Asia
Finished dosage forms and small molecules
Open article →#60FUZKK atlas leaders 1–100
Nika Pharm
Uzbekistan · South and Central Asia
Baseline manufacturing scope
Open article →#61FUZKK atlas leaders 1–100
Abdi Ibrahim
Turkey · Middle East
Diversified pharma
Open article →#62FUZKK atlas leaders 1–100
Deva Holding
Turkey · Middle East
Diversified pharma
Open article →#63FUZKK atlas leaders 1–100
Nobel Ilac
Turkey · Middle East
Baseline manufacturing scope
Open article →#64FUZKK atlas leaders 1–100
Santa Farma
Turkey · Middle East
Baseline manufacturing scope
Open article →#65FUZKK atlas leaders 1–100
Bilim Pharmaceuticals
Turkey · Middle East
Finished dosage forms and small molecules
Open article →#66FUZKK atlas leaders 1–100
CinnaGen
Iran · Middle East
BiologicsOncology / ADC / high-potency
Open article →#67FUZKK atlas leaders 1–100
AryoGen Pharmed
Iran · Middle East
Biologics
Open article →#68FUZKK atlas leaders 1–100
Actoverco
Iran · Middle East
Oncology / ADC / high-potency
Open article →#69FUZKK atlas leaders 1–100
Darou Pakhsh
Iran · Middle East
Diversified pharma
Open article →#70FUZKK atlas leaders 1–100
Exir Pharmaceutical
Iran · Middle East
Finished dosage forms and small molecules
Open article →#71FUZKK atlas leaders 1–100
SPIMACO
Saudi Arabia · Middle East
Diversified pharma
Open article →#72FUZKK atlas leaders 1–100
Tabuk Pharmaceuticals
Saudi Arabia · Middle East
Finished dosage forms and small molecules
Open article →#73FUZKK atlas leaders 1–100
Jamjoom Pharma
Saudi Arabia · Middle East
Finished dosage forms and small molecules
Open article →#74FUZKK atlas leaders 1–100
Julphar
United Arab Emirates · Middle East
Baseline manufacturing scope
Open article →#75FUZKK atlas leaders 1–100
Neopharma
United Arab Emirates · Middle East
Finished dosage forms and small molecules
Open article →#76FUZKK atlas leaders 1–100
Hikma Pharmaceuticals
Jordan · Middle East
Diversified pharmaSterile and injectable products
Open article →#77FUZKK atlas leaders 1–100
Dar Al Dawa
Jordan · Middle East
Baseline manufacturing scope
Open article →#78FUZKK atlas leaders 1–100
Pharma International
Jordan · Middle East
Finished dosage forms and small molecules
Open article →#79FUZKK atlas leaders 1–100
Apotex
Canada · Canada
Diversified pharma
Open article →#80FUZKK atlas leaders 1–100
Bausch Health
Canada · Canada
Diversified pharma
Open article →#81FUZKK atlas leaders 1–100
Pharmascience
Canada · Canada
Finished dosage forms and small molecules
Open article →#82FUZKK atlas leaders 1–100
BioVectra
Canada · Canada
API / CDMO / synthesisBiologics
Open article →#83FUZKK atlas leaders 1–100
Therapure Biopharma
Canada · Canada
API / CDMO / synthesisBiologics
Open article →#84FUZKK atlas leaders 1–100
AbCellera
Canada · Canada
Biologics
Open article →#85FUZKK atlas leaders 1–100
Zymeworks
Canada · Canada
Biologics
Open article →#86FUZKK atlas leaders 1–100
CSL
Australia · Australia and New Zealand
Diversified pharmaBiologicsVaccines and biological products
Open article →#87FUZKK atlas leaders 1–100
Telix Pharmaceuticals
Australia · Australia and New Zealand
Peptides and complex injectablesOncology / ADC / high-potencyRadiopharmaceuticals
Open article →#88FUZKK atlas leaders 1–100
Mesoblast
Australia · Australia and New Zealand
BiologicsCell and gene therapy
Open article →#89FUZKK atlas leaders 1–100
Mayne Pharma
Australia · Australia and New Zealand
Finished dosage forms and small molecules
Open article →#90FUZKK atlas leaders 1–100
IDT Australia
Australia · Australia and New Zealand
API / CDMO / synthesis
Open article →#91FUZKK atlas leaders 1–100
Douglas Pharmaceuticals
New Zealand · Australia and New Zealand
Finished dosage forms and small molecules
Open article →#92FUZKK atlas leaders 1–100
Aspen Pharmacare
South Africa · Africa
Diversified pharma
Open article →#93FUZKK atlas leaders 1–100
Adcock Ingram
South Africa · Africa
Diversified pharma
Open article →#94FUZKK atlas leaders 1–100
Biovac
South Africa · Africa
BiologicsVaccines and biological products
Open article →#95FUZKK atlas leaders 1–100
Afrigen Biologics and Vaccines
South Africa · Africa
BiologicsVaccines and biological products
Open article →#96FUZKK atlas leaders 1–100
EVA Pharma
Egypt · Africa
Diversified pharma
Open article →#97FUZKK atlas leaders 1–100
EIPICO
Egypt · Africa
Diversified pharmaSterile and injectable products
Open article →#98FUZKK atlas leaders 1–100
Pharco Pharmaceuticals
Egypt · Africa
Diversified pharma
Open article →#99FUZKK atlas leaders 1–100
Minapharm Pharmaceuticals
Egypt · Africa
Biologics
Open article →#100FUZKK atlas leaders 1–100
Sothema
Morocco · Africa
Baseline manufacturing scope
Open article →#101Extended selection 101–300
Kyorin Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#102Extended selection 101–300
Kissei Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#103Extended selection 101–300
Kaken Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#104Extended selection 101–300
Nippon Kayaku
Japan · East Asia
Oncology / ADC / high-potency
Open article →#105Extended selection 101–300
Meiji Seika Pharma
Japan · East Asia
Finished dosage forms and small molecules
Open article →#106Extended selection 101–300
Rohto Pharmaceutical
Japan · East Asia
OphthalmicsConsumer health / OTC
Open article →#107Extended selection 101–300
Towa Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#108Extended selection 101–300
Nichi-Iko Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#109Extended selection 101–300
Fuji Pharma
Japan · East Asia
Finished dosage forms and small molecules
Open article →#110Extended selection 101–300
Sanwa Kagaku Kenkyusho
Japan · East Asia
Baseline manufacturing scope
Open article →#111Extended selection 101–300
Zeria Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#112Extended selection 101–300
Senju Pharmaceutical
Japan · East Asia
Ophthalmics
Open article →#113Extended selection 101–300
Alfresa Pharma
Japan · East Asia
Finished dosage forms and small molecules
Open article →#114Extended selection 101–300
Nobelpharma
Japan · East Asia
Finished dosage forms and small molecules
Open article →#115Extended selection 101–300
Torii Pharmaceutical
Japan · East Asia
Finished dosage forms and small molecules
Open article →#116Extended selection 101–300
Dong-A ST
South Korea · East Asia
Baseline manufacturing scope
Open article →#117Extended selection 101–300
Boryung
South Korea · East Asia
Baseline manufacturing scope
Open article →#118Extended selection 101–300
JW Pharmaceutical
South Korea · East Asia
Finished dosage forms and small molecules
Open article →#119Extended selection 101–300
HK inno.N
South Korea · East Asia
Baseline manufacturing scope
Open article →#120Extended selection 101–300
Ildong Pharmaceutical
South Korea · East Asia
Finished dosage forms and small molecules
Open article →#121Extended selection 101–300
HanAll Biopharma
South Korea · East Asia
Biologics
Open article →#122Extended selection 101–300
Kolmar Korea
South Korea · East Asia
API / CDMO / synthesis
Open article →#123Extended selection 101–300
Binex
South Korea · East Asia
API / CDMO / synthesis
Open article →#124Extended selection 101–300
ABL Bio
South Korea · East Asia
Biologics
Open article →#125Extended selection 101–300
Genexine
South Korea · East Asia
Biologics
Open article →#126Extended selection 101–300
CHA Biotech
South Korea · East Asia
Biologics
Open article →#127Extended selection 101–300
Pharmicell
South Korea · East Asia
Biologics
Open article →#128Extended selection 101–300
Medytox
South Korea · East Asia
Baseline manufacturing scope
Open article →#129Extended selection 101–300
Daehan New Pharm
South Korea · East Asia
Baseline manufacturing scope
Open article →#130Extended selection 101–300
Korea United Pharm
South Korea · East Asia
Baseline manufacturing scope
Open article →#131Extended selection 101–300
Orient Pharma
Taiwan · East Asia
Finished dosage forms and small molecules
Open article →#132Extended selection 101–300
TaiGen Biotechnology
Taiwan · East Asia
BiologicsOncology / ADC / high-potency
Open article →#133Extended selection 101–300
United BioPharma
Taiwan · East Asia
Biologics
Open article →#134Extended selection 101–300
Lumosa Therapeutics
Taiwan · East Asia
Oncology / ADC / high-potency
Open article →#135Extended selection 101–300
Adimmune
Taiwan · East Asia
Vaccines and biological products
Open article →#136Extended selection 101–300
Formosa Laboratories
Taiwan · East Asia
API / CDMO / synthesis
Open article →#137Extended selection 101–300
Standard Chem & Pharm
Taiwan · East Asia
Baseline manufacturing scope
Open article →#138Extended selection 101–300
Sanbe Farma
Indonesia · Southeast Asia
Baseline manufacturing scope
Open article →#139Extended selection 101–300
Tempo Scan Pacific
Indonesia · Southeast Asia
Consumer health / OTC
Open article →#140Extended selection 101–300
Phapros
Indonesia · Southeast Asia
Baseline manufacturing scope
Open article →#141Extended selection 101–300
SOHO Global Health
Indonesia · Southeast Asia
Consumer health / OTC
Open article →#142Extended selection 101–300
Kotra Pharma
Malaysia · Southeast Asia
Finished dosage forms and small molecules
Open article →#143Extended selection 101–300
Hovid
Malaysia · Southeast Asia
Baseline manufacturing scope
Open article →#144Extended selection 101–300
Xepa-Soul Pattinson
Malaysia · Southeast Asia
Baseline manufacturing scope
Open article →#145Extended selection 101–300
CCM Pharmaceuticals
Malaysia · Southeast Asia
Finished dosage forms and small molecules
Open article →#146Extended selection 101–300
Biocon Malaysia
Malaysia · Southeast Asia
Biologics
Open article →#147Extended selection 101–300
Thai Otsuka Pharmaceutical
Thailand · Southeast Asia
Finished dosage forms and small molecules
Open article →#148Extended selection 101–300
Mega Lifesciences
Thailand · Southeast Asia
Consumer health / OTC
Open article →#149Extended selection 101–300
Berlin Pharmaceutical Industry
Thailand · Southeast Asia
Finished dosage forms and small molecules
Open article →#150Extended selection 101–300
Biolab
Thailand · Southeast Asia
Baseline manufacturing scope
Open article →#151Extended selection 101–300
Traphaco
Vietnam · Southeast Asia
Traditional and herbal medicines
Open article →#152Extended selection 101–300
Imexpharm
Vietnam · Southeast Asia
Baseline manufacturing scope
Open article →#153Extended selection 101–300
Pymepharco
Vietnam · Southeast Asia
Baseline manufacturing scope
Open article →#154Extended selection 101–300
Bidiphar
Vietnam · Southeast Asia
Baseline manufacturing scope
Open article →#155Extended selection 101–300
Domesco
Vietnam · Southeast Asia
Baseline manufacturing scope
Open article →#156Extended selection 101–300
Pascual Laboratories
Philippines · Southeast Asia
Finished dosage forms and small molecules
Open article →#157Extended selection 101–300
Lloyd Laboratories
Philippines · Southeast Asia
Finished dosage forms and small molecules
Open article →#158Extended selection 101–300
Hizon Laboratories
Philippines · Southeast Asia
Finished dosage forms and small molecules
Open article →#159Extended selection 101–300
Hyphens Pharma
Singapore · Southeast Asia
Finished dosage forms and small molecules
Open article →#160Extended selection 101–300
iX Biopharma
Singapore · Southeast Asia
Biologics
Open article →#161Extended selection 101–300
Esco Aster
Singapore · Southeast Asia
API / CDMO / synthesis
Open article →#162Extended selection 101–300
Tessa Therapeutics
Singapore · Southeast Asia
Cell and gene therapy
Open article →#163Extended selection 101–300
Martin Dow
Pakistan · South and Central Asia
Baseline manufacturing scope
Open article →#164Extended selection 101–300
High-Q Pharmaceuticals
Pakistan · South and Central Asia
Finished dosage forms and small molecules
Open article →#165Extended selection 101–300
Hilton Pharma
Pakistan · South and Central Asia
Finished dosage forms and small molecules
Open article →#166Extended selection 101–300
Ferozsons Laboratories
Pakistan · South and Central Asia
Finished dosage forms and small molecules
Open article →#167Extended selection 101–300
AGP Limited
Pakistan · South and Central Asia
Baseline manufacturing scope
Open article →#168Extended selection 101–300
Sami Pharmaceuticals
Pakistan · South and Central Asia
Finished dosage forms and small molecules
Open article →#169Extended selection 101–300
ACI Pharmaceuticals
Bangladesh · South and Central Asia
Finished dosage forms and small molecules
Open article →#170Extended selection 101–300
Healthcare Pharmaceuticals
Bangladesh · South and Central Asia
Finished dosage forms and small molecules
Open article →#171Extended selection 101–300
Eskayef Pharmaceuticals
Bangladesh · South and Central Asia
Finished dosage forms and small molecules
Open article →#172Extended selection 101–300
Beacon Pharmaceuticals
Bangladesh · South and Central Asia
Oncology / ADC / high-potency
Open article →#173Extended selection 101–300
State Pharmaceuticals Manufacturing Corporation
Sri Lanka · South and Central Asia
Finished dosage forms and small molecules
Open article →#174Extended selection 101–300
Astron Limited
Sri Lanka · South and Central Asia
Baseline manufacturing scope
Open article →#175Extended selection 101–300
Morison PLC
Sri Lanka · South and Central Asia
Baseline manufacturing scope
Open article →#176Extended selection 101–300
Abdi Ibrahim Global Pharm
Kazakhstan · South and Central Asia
Baseline manufacturing scope
Open article →#177Extended selection 101–300
Karaganda Pharmaceutical Complex
Kazakhstan · South and Central Asia
Finished dosage forms and small molecules
Open article →#178Extended selection 101–300
Dentafill Plus
Uzbekistan · South and Central Asia
Baseline manufacturing scope
Open article →#179Extended selection 101–300
Nobel Pharmsanoat
Uzbekistan · South and Central Asia
Baseline manufacturing scope
Open article →#180Extended selection 101–300
Aidan Pharma
Kyrgyzstan · South and Central Asia
Finished dosage forms and small molecules
Open article →#181Extended selection 101–300
Sanovel
Turkey · Middle East
Baseline manufacturing scope
Open article →#182Extended selection 101–300
Drogsan Pharmaceuticals
Turkey · Middle East
Finished dosage forms and small molecules
Open article →#183Extended selection 101–300
Atabay Pharmaceuticals and Fine Chemicals
Turkey · Middle East
API / CDMO / synthesis
Open article →#184Extended selection 101–300
Ilko Pharmaceuticals
Turkey · Middle East
Finished dosage forms and small molecules
Open article →#185Extended selection 101–300
World Medicine Turkey
Turkey · Middle East
Finished dosage forms and small molecules
Open article →#186Extended selection 101–300
Pharmactive
Turkey · Middle East
Finished dosage forms and small molecules
Open article →#187Extended selection 101–300
Kocak Farma
Turkey · Middle East
Baseline manufacturing scope
Open article →#188Extended selection 101–300
Biofarma
Turkey · Middle East
Baseline manufacturing scope
Open article →#189Extended selection 101–300
Vem Ilac
Turkey · Middle East
Baseline manufacturing scope
Open article →#190Extended selection 101–300
Gen Ilac
Turkey · Middle East
Baseline manufacturing scope
Open article →#191Extended selection 101–300
Abidi Pharmaceutical
Iran · Middle East
Finished dosage forms and small molecules
Open article →#192Extended selection 101–300
Sobhan Darou
Iran · Middle East
Baseline manufacturing scope
Open article →#193Extended selection 101–300
Zahravi Pharmaceutical
Iran · Middle East
Finished dosage forms and small molecules
Open article →#194Extended selection 101–300
Dana Pharmaceutical
Iran · Middle East
Finished dosage forms and small molecules
Open article →#195Extended selection 101–300
Behestan Production
Iran · Middle East
Baseline manufacturing scope
Open article →#196Extended selection 101–300
Pars Darou
Iran · Middle East
Baseline manufacturing scope
Open article →#197Extended selection 101–300
Bakhtar Bioshimi
Iran · Middle East
Baseline manufacturing scope
Open article →#198Extended selection 101–300
Avalon Pharma
Saudi Arabia · Middle East
Finished dosage forms and small molecules
Open article →#199Extended selection 101–300
Sudair Pharma
Saudi Arabia · Middle East
Finished dosage forms and small molecules
Open article →#200Extended selection 101–300
Saudi Bio
Saudi Arabia · Middle East
BiologicsVaccines and biological products
Open article →#201Extended selection 101–300
Riyadh Pharma
Saudi Arabia · Middle East
Finished dosage forms and small molecules
Open article →#202Extended selection 101–300
Jazeera Pharmaceutical Industries
Saudi Arabia · Middle East
Finished dosage forms and small molecules
Open article →#203Extended selection 101–300
Globalpharma
United Arab Emirates · Middle East
Finished dosage forms and small molecules
Open article →#204Extended selection 101–300
Pharmax Pharmaceuticals
United Arab Emirates · Middle East
Finished dosage forms and small molecules
Open article →#205Extended selection 101–300
Hayat Biotech
United Arab Emirates · Middle East
Biologics
Open article →#206Extended selection 101–300
Gulf Inject
United Arab Emirates · Middle East
Sterile and injectable products
Open article →#207Extended selection 101–300
Jerash Pharmaceuticals
Jordan · Middle East
Finished dosage forms and small molecules
Open article →#208Extended selection 101–300
Arab Pharmaceutical Manufacturing
Jordan · Middle East
Finished dosage forms and small molecules
Open article →#209Extended selection 101–300
Qatar Pharma
Qatar · Middle East
Finished dosage forms and small molecules
Open article →#210Extended selection 101–300
Qatar Life Pharma
Qatar · Middle East
Finished dosage forms and small molecules
Open article →#211Extended selection 101–300
National Pharmaceutical Industries
Oman · Middle East
Finished dosage forms and small molecules
Open article →#212Extended selection 101–300
Oman Pharmaceutical Products
Oman · Middle East
Finished dosage forms and small molecules
Open article →#213Extended selection 101–300
Algorithm Pharmaceutical Manufacturers
Lebanon · Middle East
Finished dosage forms and small molecules
Open article →#214Extended selection 101–300
Benta Pharma Industries
Lebanon · Middle East
Finished dosage forms and small molecules
Open article →#215Extended selection 101–300
Pharmaline
Lebanon · Middle East
Finished dosage forms and small molecules
Open article →#216Extended selection 101–300
Bahrain Pharma
Bahrain · Middle East
Finished dosage forms and small molecules
Open article →#217Extended selection 101–300
Kuwait Saudi Pharmaceutical Industries
Kuwait · Middle East
Finished dosage forms and small molecules
Open article →#218Extended selection 101–300
JAMP Pharma
Canada · Canada
Finished dosage forms and small molecules
Open article →#219Extended selection 101–300
KABS Laboratories
Canada · Canada
API / CDMO / synthesis
Open article →#220Extended selection 101–300
Delpharm Montreal
Canada · Canada
API / CDMO / synthesis
Open article →#221Extended selection 101–300
Sterinova
Canada · Canada
Sterile and injectable products
Open article →#222Extended selection 101–300
Pendopharm
Canada · Canada
Baseline manufacturing scope
Open article →#223Extended selection 101–300
Paladin Labs
Canada · Canada
Baseline manufacturing scope
Open article →#224Extended selection 101–300
Knight Therapeutics
Canada · Canada
Baseline manufacturing scope
Open article →#225Extended selection 101–300
Medexus Pharmaceuticals
Canada · Canada
Finished dosage forms and small molecules
Open article →#226Extended selection 101–300
Theratechnologies
Canada · Canada
Baseline manufacturing scope
Open article →#227Extended selection 101–300
Xenon Pharmaceuticals
Canada · Canada
Finished dosage forms and small molecules
Open article →#228Extended selection 101–300
Aurinia Pharmaceuticals
Canada · Canada
Finished dosage forms and small molecules
Open article →#229Extended selection 101–300
Arbutus Biopharma
Canada · Canada
Biologics
Open article →#230Extended selection 101–300
Acuitas Therapeutics
Canada · Canada
Baseline manufacturing scope
Open article →#231Extended selection 101–300
STEMCELL Technologies
Canada · Canada
BiologicsDiagnostics and analytical systems
Open article →#232Extended selection 101–300
Providence Therapeutics
Canada · Canada
Biologics
Open article →#233Extended selection 101–300
PlantForm
Canada · Canada
Biologics
Open article →#234Extended selection 101–300
Entos Pharmaceuticals
Canada · Canada
Finished dosage forms and small molecules
Open article →#235Extended selection 101–300
Resilience Biotechnologies
Canada · Canada
API / CDMO / synthesisBiologics
Open article →#236Extended selection 101–300
Northern RNA
Canada · Canada
API / CDMO / synthesis
Open article →#237Extended selection 101–300
OmniaBio
Canada · Canada
BiologicsCell and gene therapy
Open article →#238Extended selection 101–300
Fusion Pharmaceuticals
Canada · Canada
Oncology / ADC / high-potencyRadiopharmaceuticals
Open article →#239Extended selection 101–300
Alpha-9 Theranostics
Canada · Canada
Oncology / ADC / high-potencyRadiopharmaceuticals
Open article →#240Extended selection 101–300
Novocol Pharma
Canada · Canada
Sterile and injectable products
Open article →#241Extended selection 101–300
Neuren Pharmaceuticals
Australia · Australia and New Zealand
Finished dosage forms and small molecules
Open article →#242Extended selection 101–300
Clinuvel Pharmaceuticals
Australia · Australia and New Zealand
Finished dosage forms and small molecules
Open article →#243Extended selection 101–300
Starpharma
Australia · Australia and New Zealand
Finished dosage forms and small molecules
Open article →#244Extended selection 101–300
Arrotex Pharmaceuticals
Australia · Australia and New Zealand
Finished dosage forms and small molecules
Open article →#245Extended selection 101–300
Vaxxas
Australia · Australia and New Zealand
Vaccines and biological products
Open article →#246Extended selection 101–300
Imugene
Australia · Australia and New Zealand
Oncology / ADC / high-potency
Open article →#247Extended selection 101–300
Kazia Therapeutics
Australia · Australia and New Zealand
Oncology / ADC / high-potency
Open article →#248Extended selection 101–300
Noxopharm
Australia · Australia and New Zealand
Oncology / ADC / high-potency
Open article →#249Extended selection 101–300
Phebra
Australia · Australia and New Zealand
Sterile and injectable products
Open article →#250Extended selection 101–300
Luina Bio
Australia · Australia and New Zealand
API / CDMO / synthesis
Open article →#251Extended selection 101–300
BioCina
Australia · Australia and New Zealand
API / CDMO / synthesisBiologics
Open article →#252Extended selection 101–300
Cell Therapies
Australia · Australia and New Zealand
BiologicsCell and gene therapy
Open article →#253Extended selection 101–300
Dimerix
Australia · Australia and New Zealand
Baseline manufacturing scope
Open article →#254Extended selection 101–300
Botanix Pharmaceuticals
Australia · Australia and New Zealand
Finished dosage forms and small molecules
Open article →#255Extended selection 101–300
Arovella Therapeutics
Australia · Australia and New Zealand
Oncology / ADC / high-potency
Open article →#256Extended selection 101–300
AFT Pharmaceuticals
New Zealand · Australia and New Zealand
Consumer health / OTC
Open article →#257Extended selection 101–300
Pacific Edge
New Zealand · Australia and New Zealand
Diagnostics and analytical systems
Open article →#258Extended selection 101–300
Blis Technologies
New Zealand · Australia and New Zealand
Baseline manufacturing scope
Open article →#259Extended selection 101–300
Rua Bioscience
New Zealand · Australia and New Zealand
BiologicsTraditional and herbal medicines
Open article →#260Extended selection 101–300
Cipla Medpro South Africa
South Africa · Africa
Baseline manufacturing scope
Open article →#261Extended selection 101–300
Pharma-Q
South Africa · Africa
Sterile and injectable products
Open article →#262Extended selection 101–300
Austell Pharmaceuticals
South Africa · Africa
Finished dosage forms and small molecules
Open article →#263Extended selection 101–300
Kiara Health
South Africa · Africa
Baseline manufacturing scope
Open article →#264Extended selection 101–300
Actor Pharma
South Africa · Africa
Finished dosage forms and small molecules
Open article →#265Extended selection 101–300
Sonke Pharmaceuticals
South Africa · Africa
Finished dosage forms and small molecules
Open article →#266Extended selection 101–300
Specpharm Holdings
South Africa · Africa
Baseline manufacturing scope
Open article →#267Extended selection 101–300
Litha Pharma
South Africa · Africa
Finished dosage forms and small molecules
Open article →#268Extended selection 101–300
Nativa
South Africa · Africa
Consumer health / OTC
Open article →#269Extended selection 101–300
Biotech Africa
South Africa · Africa
BiologicsDiagnostics and analytical systems
Open article →#270Extended selection 101–300
Fine Chemicals Corporation
South Africa · Africa
API / CDMO / synthesis
Open article →#271Extended selection 101–300
Amoun Pharmaceutical
Egypt · Africa
Finished dosage forms and small molecules
Open article →#272Extended selection 101–300
VACSERA
Egypt · Africa
BiologicsVaccines and biological products
Open article →#273Extended selection 101–300
October Pharma
Egypt · Africa
Sterile and injectable products
Open article →#274Extended selection 101–300
Marcyrl Pharmaceutical Industries
Egypt · Africa
Sterile and injectable products
Open article →#275Extended selection 101–300
Apex Pharma
Egypt · Africa
Finished dosage forms and small molecules
Open article →#276Extended selection 101–300
Rameda
Egypt · Africa
Baseline manufacturing scope
Open article →#277Extended selection 101–300
Future Pharmaceutical Industries
Egypt · Africa
Sterile and injectable products
Open article →#278Extended selection 101–300
Delta Pharma
Egypt · Africa
Finished dosage forms and small molecules
Open article →#279Extended selection 101–300
Global Napi Pharmaceuticals
Egypt · Africa
API / CDMO / synthesis
Open article →#280Extended selection 101–300
SEDICO Pharmaceutical
Egypt · Africa
Sterile and injectable products
Open article →#281Extended selection 101–300
Gypto Pharma
Egypt · Africa
Finished dosage forms and small molecules
Open article →#282Extended selection 101–300
Cooper Pharma
Morocco · Africa
Finished dosage forms and small molecules
Open article →#283Extended selection 101–300
Pharma 5
Morocco · Africa
Finished dosage forms and small molecules
Open article →#284Extended selection 101–300
Laprophan
Morocco · Africa
Baseline manufacturing scope
Open article →#285Extended selection 101–300
Bottu
Morocco · Africa
Baseline manufacturing scope
Open article →#286Extended selection 101–300
Saidal
Algeria · Africa
Baseline manufacturing scope
Open article →#287Extended selection 101–300
Biopharm Algeria
Algeria · Africa
Baseline manufacturing scope
Open article →#288Extended selection 101–300
Frater-Razes
Algeria · Africa
Baseline manufacturing scope
Open article →#289Extended selection 101–300
El Kendi
Algeria · Africa
Baseline manufacturing scope
Open article →#290Extended selection 101–300
Merinal Laboratories
Algeria · Africa
Finished dosage forms and small molecules
Open article →#291Extended selection 101–300
Medis
Tunisia · Africa
Baseline manufacturing scope
Open article →#292Extended selection 101–300
Unimed
Tunisia · Africa
Sterile and injectable products
Open article →#293Extended selection 101–300
Teriak
Tunisia · Africa
Baseline manufacturing scope
Open article →#294Extended selection 101–300
Opalia Pharma
Tunisia · Africa
Finished dosage forms and small molecules
Open article →#295Extended selection 101–300
Fidson Healthcare
Nigeria · Africa
Baseline manufacturing scope
Open article →#296Extended selection 101–300
May & Baker Nigeria
Nigeria · Africa
Baseline manufacturing scope
Open article →#297Extended selection 101–300
Emzor Pharmaceutical Industries
Nigeria · Africa
Finished dosage forms and small molecules
Open article →#298Extended selection 101–300
Neimeth International Pharmaceuticals
Nigeria · Africa
Finished dosage forms and small molecules
Open article →#299Extended selection 101–300
Dawa Life Sciences
Kenya · Africa
Baseline manufacturing scope
Open article →#300Extended selection 101–300
Universal Corporation
Kenya · Africa
Baseline manufacturing scope
Open article →—